Colorado Rocky Mountain Health Plans Pneumatic Compression Coverage Update

Coverage Criteria and Evidence Summary

Covered with criteria

Coverage determinations and medical necessity references:

General coverage stance: Intermittent limb compression devices are proven and medically necessary in certain circumstances for prevention of deep venous thrombosis and for treatment of lymphedema or chronic venous insufficiency with edema and nonhealing lower extremity ulcers when InterQual criteria are met.

Refer to InterQual CP: Durable Medical Equipment, Pneumatic Compression Devices for specific clinical coverage criteria.

Not medically necessary / Unproven

Explicit noncoverage statements:

Not medically necessary / unproven uses: Advanced intermittent pneumatic compression devices (APCDs) for head, face, or neck lymphedema and pneumatic compression devices with high pressure/rapid inflation-deflation cycles for peripheral arterial disease are considered unproven and not medically necessary.

These uses are stated as unproven and not medically necessary in the policy.

Covered when guideline-supported

Guideline-based situations where IPC may be considered

Selected indications: IPC may be considered for patients with chronic limb‑threatening ischemia (rest pain or minor tissue loss) who are not candidates for revascularization (ESVS grade 2B; AHA/ACC grade 2B).

References: ESVS 2019; AHA/ACC 2024

Venous leg ulcers: For active venous leg ulcers, IPC should be considered when other compression options are not available, cannot be used, or have failed to promote ulcer healing (ESVS grade 2a).

Standard compression (multilayer/IB/ACG) with target ankle pressure ≥40 mm Hg is recommended first-line (ESVS grade 1A).

DVT prevention evidence and coverage considerations

Evidence summary for DVT prevention — coverage nuance by population and combination therapy

Postoperative non-arthroplasty/selected surgical patients: IPC reduces DVT compared with no prophylaxis in selected postsurgical adult populations; evidence is favorable but heterogeneous. Combining IPC with pharmacologic prophylaxis has been shown in some reviews to reduce DVT more than pharmacologic prophylaxis alone (certainty low to moderate).

ECRI assessments and systematic reviews indicate benefit in selected surgical groups; study heterogeneity limits generalizability

Critically ill patients: Systematic reviews and an RCT indicate IPC alone or with anticoagulation reduces DVT/VTE incidence compared with no prophylaxis in critically ill adults, but whether adding IPC to pharmacologic prophylaxis reduces DVT further is unclear.

ECRI 2025b and supporting RCTs show mixed precision and heterogeneity

ICU adjunctive IPC with pharmacologic prophylaxis: A large multicenter RCT (n=2,003) found no reduction in proximal DVT when adjunctive IPC was added to pharmacologic thromboprophylaxis in critically ill adults.

Therapeutic IPC — PAD, CLI, venous disease

Therapeutic use for PAD, CLI, lymphedema, and chronic venous insufficiency

PAD/claudication: Small trials and systematic reviews report IPC can increase arterial flow and walking distance in intermittent claudication, but studies are small and heterogeneous, limiting confidence in the effect size.

Williams et al.; Hayes HTA note uncertainty

CLI when nonreconstructable: High‑pressure IPC (HPIPC) trials in patients not candidates for revascularization have reported improved peak walking time, wound healing, pain relief, and functional measures in small RCTs, but sample sizes and study quality limit generalizability.

Alvarez et al. 2015 RCT; ECRI inclusion

Venous ulcers and lymphedema: Randomized trials show IPC used as an adjunct to standard compression can accelerate healing and reduce pain in hard‑to‑heal venous ulcers compared with compression alone.

Alvarez et al. 2020; Lurie et al. 2017 showed benefits or comparable outcomes vs stockings

Evidence summary / coverage implications

Evidence- and guideline-informed coverage considerations derived from cited studies and recommendations

IPC effective for DVT prevention in select populations: Randomized trials and meta-analyses demonstrate IPC reduces DVT incidence in immobile post‑stroke patients (CLOTS 3) and in some postoperative immobilized patients; combined mechanical plus pharmacologic prophylaxis may reduce PE and DVT versus pharmacologic prophylaxis alone in some pooled analyses. Benefits vary by population, and adverse events and adherence issues are reported.

CLOTS 3: absolute risk reduction 3.6%; Cochrane and other meta-analyses report reduced PE/DVT with combined prophylaxis (certainty varies).

Advanced pneumatic compression devices (APCDs) intended to treat lymphedema of the head, face, or neck are considered unproven and not medically necessary. The policy cites insufficient peer-reviewed evidence to establish efficacy, clinical value, or safety for APCDs in these anatomic regions and indicates that additional research is required to define their role.

Pneumatic compression systems that operate at high pressures with rapid inflation/deflation cycles for the treatment of peripheral arterial disease (PAD) are also judged unproven and not medically necessary. The evidence for benefit on patient-centered outcomes in PAD is inconsistent and insufficient to support routine coverage of these high-pressure devices.

Evidence comparing intermittent pneumatic compression (IPC) with standard compression after peripheral bypass surgery is limited; published data do not demonstrate that IPC consistently reduces edema compared with compression stockings in this setting. Health-technology assessments note substantial uncertainty because of poor-quality or heterogeneous studies.

In surgical populations such as total knee arthroplasty, systematic reviews and HTAs conclude that pneumatic compression may reduce DVT when combined with low-molecular-weight heparin (LMWH), but IPC alone is less effective than LMWH alone. Thus, IPC used in place of guideline-recommended pharmacologic prophylaxis is not supported by consistent high-quality evidence.

Mechanical prophylaxis, including IPC, should not be used in patients with suspected or proven peripheral arterial disease (PAD) or other conditions listed by guidance (e.g., peripheral arterial bypass grafting, peripheral neuropathy with sensory impairment, fragile skin, gangrene, recent skin graft, severe leg edema, or limb deformity that prevents proper fit). These contraindications reflect safety concerns where compression could cause harm or be ineffective.

Restating policy exclusions: APCDs designed for the head, face, or neck and pneumatic compression devices that use high-pressure rapid inflation/deflation cycles for arterial insufficiency are classified as unproven and not medically necessary. The policy draws on the lack of sufficient efficacy and safety data to exclude these device categories from coverage.

For PAD and chronic limb‑threatening ischemia (CLI), evidence is limited and inconsistent. Some small trials report improvements in walking distance, pain, or wound healing with IPC or high-pressure regimens, but many studies are at high risk of bias, heterogeneous in treatment protocols, and lack robust, patient‑centered outcome data. As a result, use of IPC/HPIPC for PAD/CLI has insufficient high-quality evidence to demonstrate clear benefit over standard therapies in most situations.

The evidence for pneumatic compression used alone versus pharmacologic prophylaxis in some surgical populations is limited and inconsistent. Meta-analyses and HTAs report that IPC may reduce DVT compared with no prophylaxis, but when compared with pharmacologic agents (e.g., LMWH) the data are heterogeneous and in several analyses IPC alone was not superior to chemoprophylaxis. This uncertainty supports careful selection of patients and adherence to guideline-recommended sequencing of mechanical and pharmacologic prophylaxis.

Applicable Codes and Coding Notes

Applicable HCPCS CodesHCPCS

A4600	Sleeve for intermittent limb compression device, replacement only, each.
E0650	Pneumatic compressor, nonsegmental home model.
E0651	Pneumatic compressor, segmental home model without calibrated gradient pressure.
E0652	Pneumatic compressor, segmental home model with calibrated gradient pressure.
E0655	Nonsegmental pneumatic appliance for use with pneumatic compressor, half arm.
E0658	Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full arms and chest.
E0659	Segmental pneumatic appliance for use with pneumatic compressor, integrated, head, neck and chest.
E0660	Nonsegmental pneumatic appliance for use with pneumatic compressor, full leg.
E0665	Nonsegmental pneumatic appliance for use with pneumatic compressor, full arm.
E0666	Nonsegmental pneumatic appliance for use with pneumatic compressor, half leg.

1–10 of 19

1/2

High-pressure IPC regimen durations referenced in studies

Example HPIPC regimen (Alvarez 2015)60 minutes twice daily for 16 weeks (study of 18 participants receiving HPIPC vs exercise).

Alternate HPIPC regimen reported2 hours daily for 16 weeks (reported as an effective regimen in the HPIPC literature).

Regimen variabilityClinical trials used differing session lengths and total treatment durations; optimal device/session/total treatment length not clearly identified.

Prior Authorization, Sequencing, and Actionable Guidance

Prior Authorization

Prior Authorization Required

Prior authorization required per InterQual criteria for pneumatic and intermittent limb compression devices. Coverage and medical necessity are governed by the InterQual® CP: Durable Medical Equipment, Pneumatic Compression Devices subset; submit requests to the plan for prior authorization and include documentation showing InterQual criteria are met.

Prior authorization required when InterQual criteria apply
Include InterQual rationale/decision support with request

Prior Authorization

Prior Authorization for Selected IPC Use

Prior authorization is required for selected uses of intermittent pneumatic compression (IPC) — e.g., CLI without revascularization options, venous leg ulcers when standard compression has failed or is not tolerated, or other clinically selected patients. Provide clinical justification linking the case to guideline- or evidence-supported indications.

Common selected IPC uses: CLI without revascularization options; chronic venous insufficiency with nonhealing VLU after standard compression failure or intolerance

Medical Necessity Determinations and Indications

InterQual-based necessity

High-level criteria approach — specific rules are in InterQual:

InterQual-dependent coverage: Coverage for DME pneumatic compression devices requires meeting InterQual CP clinical criteria for the specific indication (e.g., lymphedema, chronic venous insufficiency with nonhealing lower extremity ulcers, or DVT prevention).

Refer to InterQual for the full decision logic and required clinical documentation.

DME medical necessity for IPC

When IPC may meet medical necessity

CLI without revascularization: Patient has chronic limb‑threatening ischemia (rest pain or minor tissue loss) and is not a candidate for revascularization; IPC may be considered to augment wound healing or reduce rest pain.

ESVS and AHA/ACC guidelines (grade 2B)

Rental, Purchase, and Device Listings

HCPCS code	Description	Coverage status
A4600
Sleeve for intermittent limb compression device, replacement only, each.
neutral
E0650
Pneumatic compressor, nonsegmental home model.
neutral
E0651
Pneumatic compressor, segmental home model without calibrated gradient pressure.
neutral
E0652
Pneumatic compressor, segmental home model with calibrated gradient pressure.
neutral
E0655
Nonsegmental pneumatic appliance for use with pneumatic compressor, half arm.
neutral
E0658
Segmental pneumatic appliance for use with pneumatic compressor, integrated, 2 full arms and chest.
neutral
E0659
Segmental pneumatic appliance for use with pneumatic compressor, integrated, head, neck and chest.
neutral
E0660
Nonsegmental pneumatic appliance for use with pneumatic compressor, full leg.
neutral
E0665
Nonsegmental pneumatic appliance for use with pneumatic compressor, full arm.
neutral
E0666
Nonsegmental pneumatic appliance for use with pneumatic compressor, half leg.
neutral
E0667
Segmental pneumatic appliance for use with pneumatic compressor, full leg.
neutral
E0668
Segmental pneumatic appliance for use with pneumatic compressor, full arm.
neutral
E0669
Segmental pneumatic appliance for use with pneumatic compressor, half leg.
neutral
E0670
Segmental pneumatic appliance for use with pneumatic compressor, integrated, two full legs and trunk.
neutral
E0671
Segmental gradient pressure pneumatic appliance, full leg.
neutral
E0672
Segmental gradient pressure pneumatic appliance, full arm.
neutral
E0673
Segmental gradient pressure pneumatic appliance, half leg.
neutral
E0675
Pneumatic compression device, high pressure, rapid inflation/deflation cycle, for arterial insufficiency (unilateral or bilateral system).
neutral
E0676
Intermittent limb compression device (includes all accessories), not otherwise specified
neutral

Device category	Notes from policy excerpt	Coverage status
Intermittent pneumatic compression devices (IPC)
Devices used for DVT prevention and some therapeutic indications; evidence varies by population and setting per Hayes and systematic reviews.
neutral
High-pressure IPC (HPIPC) systems
Studied for PAD/CLI in small RCTs with variable results; evidence limited and inconsistent; some HPIPC devices considered unproven for PAD/arterial insufficiency.
neutral
Pneumatic appliances/garments (segmental and nonsegmental)
Includes full leg, half leg, full arm, half arm, integrated garments; used with compressors in home and clinical settings.
neutral
Advanced APCDs for head/face/neck
Advanced systems (e.g., Flexitouch) have device-specific indications but are considered unproven/not medically necessary for head/face/neck lymphedema in this policy excerpt.
neutral

Device / HCPCS	Policy guidance or note	Coverage status
Flexitouch Plus System / E0659 (garment for head, neck and chest)
FDA-cleared for head and neck lymphedema (informational); policy states advanced APCDs for head/face/neck lymphedema are unproven/not medically necessary in this excerpt.
neutral
High-pressure rapid inflation/deflation systems / E0675
Described in coding list; policy indicates HP rapid-cycle devices for arterial insufficiency are considered unproven and may be not medically necessary for PAD.
neutral
Standard home compressors / E0650, E0651, E0652
Home model pneumatic compressors listed; specific rental vs purchase rules not specified in the excerpt — refer to InterQual/plan guidance for DME rules.
neutral
Intermittent limb compression device, NOS / E0676
Catch-all code for devices and accessories; policy lists code but does not provide device-specific rental/purchase rules in this fragment.
neutral

Replacement and Repair Guidance

Replacement interval specified in policy excerptNo replacement interval specified in this policy excerpt.

HCPCS replacement codeA4600 listed as sleeve replacement-only code; policy lists codes but does not define replacement timing.

Rental/purchase guidancePolicy lists HCPCS codes for compressors and appliances but does not provide explicit rental vs purchase or replacement rules in this document segment.

IPC devices — replacement considerations

Replacement interval for IPC devicesNot specified in this document segment (no explicit replacement rules provided).

Documentation and codingIPC devices are listed among applicable HCPCS codes (E0676, E0660, E0666, etc.), but replacement timing is not described here.

Definitions

Intermittent pneumatic compression — definition

DefinitionIntermittent pneumatic compression (IPC) uses an air compressor with garments that sequentially inflate and deflate to apply pressure against the skin, reducing venous stasis and stimulating fibrinolytic factors.

Typical formInflatable sleeves wrapped around the legs (calf or calf+thigh) secured by Velcro; may inflate distally then proximally to increase venous flow.

Indications referencedUsed for DVT prevention, lymphedema, chronic venous insufficiency with edema and nonhealing ulcers, and studied for PAD/CLI.

Advanced pneumatic compression devices (APCDs)

DefinitionAdvanced pneumatic compression devices (APCDs) are more complex systems with multiple garment options and programmability to address fibrosis, head/face/neck edema, chronic wounds, or localized swelling.

Device features

Documentation Requirements and Examples

Documentation Required

Maintain medical record documentation to support InterQual review

Medical records must include documentation that supports InterQual medical necessity criteria when requested; ensure contemporaneous notes, objective findings, and prior treatment history are available for review.

Medical records documentation may be required to assess whether the member meets InterQual clinical criteria.
Provide requested records to support authorization and claims reviews.

Documentation Required

Document physician justification for guideline‑based indications and conservative therapy failure

Physician documentation should explicitly support guideline‑based indications and prior conservative therapy — examples include documentation that the patient is nonreconstructable CLI, has a hard‑to‑heal venous ulcer, or has failed/intolerant compression therapy.

For CLI: document that revascularization is not feasible and include relevant vascular assessments.
For VLU: document duration, size, and prior compression therapies and their outcomes.

Not Covered / Experimental Uses

Advanced APCDs intended for head/face/neck lymphedema and high-pressure rapid‑cycle pneumatic compression devices for arterial insufficiency are listed as not covered because they are considered unproven; the policy cites insufficient evidence on efficacy and safety to support coverage.

Duplicate/alternate phrasing: APCDs for head/face/neck lymphedema and high-pressure rapid‑cycle devices for PAD are expressly considered not medically necessary due to lack of robust evidence supporting clinical benefit.

Use of IPC as a substitute for established pharmacologic VTE prophylaxis is not supported in settings where anticoagulation is indicated. Systematic reviews and HTAs indicate that in many surgical contexts IPC alone is less effective than pharmacologic prophylaxis, and combined therapy may be needed for optimal risk reduction.

Similarly, use of pneumatic compression alone in place of effective pharmacologic prophylaxis (for example, LMWH where indicated after knee arthroplasty) is considered not covered when evidence demonstrates superiority or equivalence of pharmacologic approaches and IPC alone lacks consistent support.

Background and Scope

Pneumatic compression devices are mechanical systems that use an air compressor connected to garments or sequential sleeves that inflate and deflate to apply external pressure. They are intended to reduce edema and improve venous and lymphatic flow by sequential compression of the limb or treated anatomic region.

Policy Revision History

2026-06-01revisionLatest

Revised medical necessity clinical coverage language and replaced InterQual reference with 'InterQual CP: Durable Medical Equipment, Pneumatic Compression Devices'; updated Clinical Evidence and References; archived prior policy version 2026T0563W.